Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe vs Nutraceuticals in Statin-Intolerant Post-PCI Patients (ECLIPSE)
NCT01490229Phase 4Unknown
- Sponsor
- Sapienza University of Rome
- Start
- Jan 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe in coronary artery disease (CAD), hypercholesterolemia, sponsored by Sapienza University of Rome. Status: unknown.
02
Drugs
ezetimibe
03
Conditions
coronary artery disease (CAD)hypercholesterolemia
Beyond the preview
Go deeper on NCT01490229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01490229.